Navigation Links
Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio
Date:2/4/2008

Bayview Increases High-Field MR Imaging Services to Unprecedented Number of

Claustrophobic, Elderly and Bariatric Patients

MALVERN, Pa., Feb. 4 /PRNewswire-FirstCall/ -- Johns Hopkins Bayview Medical Center in Baltimore has become the first facility in the United States to install the newest magnetic resonance imaging (MRI) system from Siemens Medical Solutions (http://www.usa.siemens.com/healthcare) -- the MAGNETOM(R) Verio. Combining 3 Tesla (T) strength and sensitivity with a 70-cm open bore and Tim(TM) (Tot al imaging mat rix) technology, the MAGNETOM Verio is helping Hopkins Bayview to provide high-field imaging to many patients who previously could not benefit from the technology.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

Certain patients, such as children or adults experiencing excessive pain or limited mobility, and the elderly, have had difficulty tolerating MRI exams. However, the Verio's short length -- the shortest 3T on the market today -- along with its large bore -- the widest 3T available -- can help reduce a patient's anxiety and discomfort. Furthermore, due to the system's wide bore and a 550-pound table-weight capacity, the MAGNETOM Verio enables clinicians to image and diagnose many obese patients, an increasingly important factor as one-in-three Americans is considered obese.

"The Verio is an exciting addition to our facility because it enables us to provide high-field imaging to new patient populations, including our bariatric patients," said Dr. Mark E. Bohlman, chairman of imaging at Johns Hopkins Bayview Medical Center. "Furthermore, the Verio is already being used to assist our clinicians in new ways, such as scanning for viable cartilage for transplant and helping create neurosurgical, pre-op planning maps."

With
'/>"/>

SOURCE Siemens Medical Solutions
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
2. Johnson & Johnson Announces Changes to Accelerate Growth
3. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
4. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
5. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
6. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
7. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
8. RG Global Corporate Update: First Coal Bed Methane Water Treatment Plant Near Completion; Expanding Water Treatment Applications
9. Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access
10. Access Pharmaceuticals Announces $2.7 Million New Equity
11. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... (Nasdaq: DNDN ) announced today that the ... exercised in full their option to purchase an ... public offering price of $24.75 per share. ... of the offering to an aggregate of 17,250,000 ... receive net proceeds from the offering of approximately ...
(Date:12/11/2009)... 11 Ambit Biosciences Corporation announced today the ... D. Anderson Cancer Center of the first patient in ... E fficacy) Phase 2 pivotal trial in ... AC220 is a novel, orally available, potent and ... a FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ACE ...
(Date:12/11/2009)... 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ... the appointment of Dr. Alan Warrander to the ... Business Development. ,, "Dr. Warrander will be responsible ... for REOLYSIN(R)," said Dr. Brad Thompson, President and ... the design of a Phase 3 trial examining ...
(Date:12/10/2009)... Calif., Dec. 10 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today that Dan Lemaitre, ... the Endologix Board of Directors effective December 11, ... and three non-independent directors. ,, Franklin D. Brown, ... to welcome Dan Lemaitre to the Endologix Board ...
Breaking Biology Technology:Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2
... Interactive, to Head New Division, AUSTIN, Texas, ... in marketing to customers across the entire healthcare,continuum, ... 25,independent healthcare firms, has established a full-scale digital,division., ... offer clients expanded,digital capabilities, including strategy; web design ...
... Powerful Approach to Modeling Complex ... Biological Systems for Type 2 Diabetes, ... systems,biology company focused on identifying molecular mechanisms, networks and,biomarkers ... joint collaboration with Sirtris Pharmaceuticals, Inc. (Nasdaq: SIRT ...
... Significant Accomplishment for the PLSG and the Life Sciences Industry ... ... April 30 The Pittsburgh Life Sciences,Greenhouse (PLSG), the organization ... to the region,s,life sciences enterprises, announced that the PLSG has ...
Other Biology Technology:HC&B Healthcare Launches HC&B Digital 2HC&B Healthcare Launches HC&B Digital 3Genstruct and Sirtris Pharmaceuticals Win Bio-IT World's Best Practices Award 2The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments 2The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments 3
(Date:12/11/2009)... growers, profits have traditionally been limited by ... growing seasons can be short. Thanks to ... are being introduced that offer growers the ... in economic bonuses for both producers and ... of blackberry called "primocane-fruiting", which bear fruit ...
(Date:12/11/2009)... available in German . , ... plant introductions than extinctions, plant communities of many ... species are occurring more frequently, whereas rare species ... biological communities that are becoming increasingly similar, but ... have led to a loss of uniqueness among ...
(Date:12/11/2009)... from 190 nations are gathered at the two-week ... about 150 distinguished guests attended an ESA-hosted side ... Essential Climate Variables,. , During the event, speakers ... observation satellites play in providing systematic global climate ... research and for managing mitigation and adaptation strategies. ...
Breaking Biology News(10 mins):New management methods extend blackberry season 2Europe's flora is becoming impoverished 2Europe's flora is becoming impoverished 3Space agencies join forces to systematically observe climate variables 2Space agencies join forces to systematically observe climate variables 3Reportlinker Adds Outsourcing Preclinical Studies to China 5707 1Reportlinker Adds Outsourcing Preclinical Studies to China 5707 2Reportlinker Adds Outsourcing Preclinical Studies to China 5707 3Reportlinker Adds Outsourcing Preclinical Studies to China 5707 4Reportlinker Adds Outsourcing Preclinical Studies to China 5707 5Reportlinker Adds Outsourcing Preclinical Studies to China 5707 6DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call 5704 1DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call 5704 2Exposure to Holocaust May Have Raised Cancer Risks 60111 1Exposure to Holocaust May Have Raised Cancer Risks 60111 2
... Oct. 2, 2007The Keck School of Medicine of the University ... from the Kenneth T. & Eileen L. Norris Foundation that ... research centers devoted to the study of epigenetics. , The ... researcha field that holds great promise in the treatment and ...
... Rochester Institute of Technology professor James Winebrake had more ... at Shenandoah National Park in Virginia has solidified into ... to identify ways to make historic sites energy efficient ... won a $350,000 grant from the National Park Service ...
... gradient greenhouse in order to study the impact of ... for studying the simultaneous effect of increased CO2 and ... by researchers from the area of Plant Biology of ... studies in this area. , These studies, financed by ...
Other Biology News:$10 million gift to support cutting-edge epigenome center at USC 2$10 million gift to support cutting-edge epigenome center at USC 3Universities partner with national parks to give historic sites energy makeovers 2A greenhouse in order to study the impact of climate change on plants 2
Fingerprinting II Informatix cluster analysis is an optional module that adds dendrogram and phylogenetic tree construction, cluster and group significance, and congruence of techniques functions to ...
... identification and library manager ... that adds capabilities for ... identification of unknowns against ... of the same taxon ...
Fingerprinting II Informatix optional matrix types module, is an optional module that adds external similarity and distance matrix functions to the Fingerprinting II Informatix software package....
... microarrays are derived from frozen embedded tissue ... control procedures to ensure the highest quality. ... in one block, sectioned at a thickness ... slides. Sections are large (3-5 mm in ...
Biology Products: